Diarylquinoline

Diarylquinoline
Drug class
Bedaquiline is the founding member of this class
Class identifiers
UseAnti-tuberculosis drug
Mechanism of actionInhibitor
Biological targetsubunit c of ATP synthase
Chemical classDiarylquinoline
External links
MeSHD064687
Legal status
In Wikidata

Diarylquinolines (DARQs) are a chemical class of drugs that treat tuberculosis. They target subunit c of mycobacterial ATP synthase, inhibiting the enzyme so mycobacterium tuberculosis cannot synthesise ATP. This effectively kills the bacteria.

Although ATP synthase in bacteria is similar to its eukaryotic analogue, diarylquinoline agents (such as TMC207) are very specific to the bacterial enzyme, so were expected to be safe for use in humans and other eukaryotes. This also suggests that bacterial ATP synthase inhibition is an attractive therapeutic target.